Global Interventional Oncology Device Market Growth 2020-2025
According to this study, over the next five years the Interventional Oncology Device market will register a XX%% CAGR in terms of revenue, the global market size will reach $ XX million by 2025, from $ XX million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Interventional Oncology Device business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Interventional Oncology Device market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Interventional Oncology Device, covering the supply chain analysis, impact assessment to the Interventional Oncology Device market size growth rate in several scenarios, and the measures to be undertaken by Interventional Oncology Device companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Ablation Devices
Embolization Devices
Supporting Devices
Next Generation Devices
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospitals
Specialty Clinics and Ambulatory Surgical Centers
Others (Homecare and Research Institutes)
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
AngioDynamics, Inc.
Merit Medical Systems, Inc.
BD
BTG Plc
Eckert & Ziegler BEBIG
Boston Scientific Corporation
Medtronic PLC
HealthTronics, Inc.
Medwaves, Inc.
IceCure Medical
Cook Meidical LLC
Sanarus Technologies, Inc.
Terumo Corporation
Sonacare Medical
Trod Medical
Sirtex Medical Ltd.
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Interventional Oncology Device consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Interventional Oncology Device market by identifying its various subsegments.
Focuses on the key global Interventional Oncology Device manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Interventional Oncology Device with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Interventional Oncology Device submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Interventional Oncology Device Consumption 2015-2025
2.1.2 Interventional Oncology Device Consumption CAGR by Region
2.2 Interventional Oncology Device Segment by Type
2.2.1 Ablation Devices
2.2.2 Embolization Devices
2.2.3 Supporting Devices
2.2.4 Next Generation Devices
2.3 Interventional Oncology Device Consumption by Type
2.3.1 Global Interventional Oncology Device Consumption Market Share by Type (2015-2020)
2.3.2 Global Interventional Oncology Device Revenue and Market Share by Type (2015-2020)
2.3.3 Global Interventional Oncology Device Sale Price by Type (2015-2020)
2.4 Interventional Oncology Device Segment by Application
2.4.1 Hospitals
2.4.2 Specialty Clinics and Ambulatory Surgical Centers
2.4.3 Others (Homecare and Research Institutes)
2.5 Interventional Oncology Device Consumption by Application
2.5.1 Global Interventional Oncology Device Consumption Market Share by Type (2015-2020)
2.5.2 Global Interventional Oncology Device Value and Market Share by Type (2015-2020)
2.5.3 Global Interventional Oncology Device Sale Price by Type (2015-2020)
3 Global Interventional Oncology Device by Company
3.1 Global Interventional Oncology Device Sales Market Share by Company
3.1.1 Global Interventional Oncology Device Sales by Company (2018-2020)
3.1.2 Global Interventional Oncology Device Sales Market Share by Company (2018-2020)
3.2 Global Interventional Oncology Device Revenue Market Share by Company
3.2.1 Global Interventional Oncology Device Revenue by Company (2018-2020)
3.2.2 Global Interventional Oncology Device Revenue Market Share by Company (2018-2020)
3.3 Global Interventional Oncology Device Sale Price by Company
3.4 Global Interventional Oncology Device Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Interventional Oncology Device Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Interventional Oncology Device Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Interventional Oncology Device by Regions
4.1 Interventional Oncology Device by Regions
4.2 Americas Interventional Oncology Device Consumption Growth
4.3 APAC Interventional Oncology Device Consumption Growth
4.4 Europe Interventional Oncology Device Consumption Growth
4.5 Middle East & Africa Interventional Oncology Device Consumption Growth
5 Americas
5.1 Americas Interventional Oncology Device Consumption by Countries
5.1.1 Americas Interventional Oncology Device Consumption by Countries (2015-2020)
5.1.2 Americas Interventional Oncology Device Value by Countries (2015-2020)
5.2 Americas Interventional Oncology Device Consumption by Type
5.3 Americas Interventional Oncology Device Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Interventional Oncology Device Consumption by Regions
6.1.1 APAC Interventional Oncology Device Consumption by Regions (2015-2020)
6.1.2 APAC Interventional Oncology Device Value by Regions (2015-2020)
6.2 APAC Interventional Oncology Device Consumption by Type
6.3 APAC Interventional Oncology Device Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Interventional Oncology Device by Countries
7.1.1 Europe Interventional Oncology Device Consumption by Countries (2015-2020)
7.1.2 Europe Interventional Oncology Device Value by Countries (2015-2020)
7.2 Europe Interventional Oncology Device Consumption by Type
7.3 Europe Interventional Oncology Device Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Interventional Oncology Device by Countries
8.1.1 Middle East & Africa Interventional Oncology Device Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Interventional Oncology Device Value by Countries (2015-2020)
8.2 Middle East & Africa Interventional Oncology Device Consumption by Type
8.3 Middle East & Africa Interventional Oncology Device Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Interventional Oncology Device Distributors
10.3 Interventional Oncology Device Customer
11 Global Interventional Oncology Device Market Forecast
11.1 Global Interventional Oncology Device Consumption Forecast (2021-2025)
11.2 Global Interventional Oncology Device Forecast by Regions
11.2.1 Global Interventional Oncology Device Forecast by Regions (2021-2025)
11.2.2 Global Interventional Oncology Device Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Interventional Oncology Device Forecast by Type
11.8 Global Interventional Oncology Device Forecast by Application
12 Key Players Analysis
12.1 AngioDynamics, Inc.
12.1.1 Company Information
12.1.2 Interventional Oncology Device Product Offered
12.1.3 AngioDynamics, Inc. Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 AngioDynamics, Inc. Latest Developments
12.2 Merit Medical Systems, Inc.
12.2.1 Company Information
12.2.2 Interventional Oncology Device Product Offered
12.2.3 Merit Medical Systems, Inc. Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Merit Medical Systems, Inc. Latest Developments
12.3 BD
12.3.1 Company Information
12.3.2 Interventional Oncology Device Product Offered
12.3.3 BD Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 BD Latest Developments
12.4 BTG Plc
12.4.1 Company Information
12.4.2 Interventional Oncology Device Product Offered
12.4.3 BTG Plc Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 BTG Plc Latest Developments
12.5 Eckert & Ziegler BEBIG
12.5.1 Company Information
12.5.2 Interventional Oncology Device Product Offered
12.5.3 Eckert & Ziegler BEBIG Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Eckert & Ziegler BEBIG Latest Developments
12.6 Boston Scientific Corporation
12.6.1 Company Information
12.6.2 Interventional Oncology Device Product Offered
12.6.3 Boston Scientific Corporation Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Boston Scientific Corporation Latest Developments
12.7 Medtronic PLC
12.7.1 Company Information
12.7.2 Interventional Oncology Device Product Offered
12.7.3 Medtronic PLC Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Medtronic PLC Latest Developments
12.8 HealthTronics, Inc.
12.8.1 Company Information
12.8.2 Interventional Oncology Device Product Offered
12.8.3 HealthTronics, Inc. Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 HealthTronics, Inc. Latest Developments
12.9 Medwaves, Inc.
12.9.1 Company Information
12.9.2 Interventional Oncology Device Product Offered
12.9.3 Medwaves, Inc. Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Medwaves, Inc. Latest Developments
12.10 IceCure Medical
12.10.1 Company Information
12.10.2 Interventional Oncology Device Product Offered
12.10.3 IceCure Medical Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 IceCure Medical Latest Developments
12.11 Cook Meidical LLC
12.11.1 Company Information
12.11.2 Interventional Oncology Device Product Offered
12.11.3 Cook Meidical LLC Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Cook Meidical LLC Latest Developments
12.12 Sanarus Technologies, Inc.
12.12.1 Company Information
12.12.2 Interventional Oncology Device Product Offered
12.12.3 Sanarus Technologies, Inc. Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Sanarus Technologies, Inc. Latest Developments
12.13 Terumo Corporation
12.13.1 Company Information
12.13.2 Interventional Oncology Device Product Offered
12.13.3 Terumo Corporation Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Terumo Corporation Latest Developments
12.14 Sonacare Medical
12.14.1 Company Information
12.14.2 Interventional Oncology Device Product Offered
12.14.3 Sonacare Medical Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Sonacare Medical Latest Developments
12.15 Trod Medical
12.15.1 Company Information
12.15.2 Interventional Oncology Device Product Offered
12.15.3 Trod Medical Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 Trod Medical Latest Developments
12.16 Sirtex Medical Ltd.
12.16.1 Company Information
12.16.2 Interventional Oncology Device Product Offered
12.16.3 Sirtex Medical Ltd. Interventional Oncology Device Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Sirtex Medical Ltd. Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Interventional Oncology Device Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Ablation Devices
Table 5. Major Players of Embolization Devices
Table 6. Major Players of Supporting Devices
Table 7. Major Players of Next Generation Devices
Table 8. Global Consumption Sales by Type (2015-2020)
Table 9. Global Interventional Oncology Device Consumption Market Share by Type (2015-2020)
Table 10. Global Interventional Oncology Device Revenue by Type (2015-2020) ($ million)
Table 11. Global Interventional Oncology Device Value Market Share by Type (2015-2020) ($ Millions)
Table 12. Global Interventional Oncology Device Sale Price by Type (2015-2020)
Table 13. Global Consumption Sales by Application (2015-2020)
Table 14. Global Interventional Oncology Device Consumption Market Share by Application (2015-2020)
Table 15. Global Interventional Oncology Device Value by Application (2015-2020)
Table 16. Global Interventional Oncology Device Value Market Share by Application (2015-2020)
Table 17. Global Interventional Oncology Device Sale Price by Application (2015-2020)
Table 18. Global Interventional Oncology Device Sales by Company (2017-2019) (K Units)
Table 19. Global Interventional Oncology Device Sales Market Share by Company (2017-2019)
Table 20. Global Interventional Oncology Device Revenue by Company (2017-2019) ($ Millions)
Table 21. Global Interventional Oncology Device Revenue Market Share by Company (2017-2019)
Table 22. Global Interventional Oncology Device Sale Price by Company (2017-2019)
Table 23. Global Interventional Oncology Device Manufacturing Base Distribution and Sales Area by Manufacturers
Table 24. Players Interventional Oncology Device Products Offered
Table 25. Interventional Oncology Device Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 26. Global Interventional Oncology Device Consumption by Regions 2015-2020 (K Units)
Table 27. Global Interventional Oncology Device Consumption Market Share by Regions 2015-2020
Table 28. Global Interventional Oncology Device Value by Regions 2015-2020 ($ Millions)
Table 29. Global Interventional Oncology Device Value Market Share by Regions 2015-2020
Table 30. Americas Interventional Oncology Device Consumption by Countries (2015-2020) (K Units)
Table 31. Americas Interventional Oncology Device Consumption Market Share by Countries (2015-2020)
Table 32. Americas Interventional Oncology Device Value by Countries (2015-2020) ($ Millions)
Table 33. Americas Interventional Oncology Device Value Market Share by Countries (2015-2020)
Table 34. Americas Interventional Oncology Device Consumption by Type (2015-2020) (K Units)
Table 35. Americas Interventional Oncology Device Consumption Market Share by Type (2015-2020)
Table 36. Americas Interventional Oncology Device Consumption by Application (2015-2020) (K Units)
Table 37. Americas Interventional Oncology Device Consumption Market Share by Application (2015-2020)
Table 38. APAC Interventional Oncology Device Consumption by Countries (2015-2020) (K Units)
Table 39. APAC Interventional Oncology Device Consumption Market Share by Countries (2015-2020)
Table 40. APAC Interventional Oncology Device Value by Regions (2015-2020) ($ Millions)
Table 41. APAC Interventional Oncology Device Value Market Share by Regions (2015-2020)
Table 42. APAC Interventional Oncology Device Consumption by Type (2015-2020) (K Units)
Table 43. APAC Interventional Oncology Device Consumption Market Share by Type (2015-2020)
Table 44. APAC Interventional Oncology Device Consumption by Application (2015-2020) (K Units)
Table 45. APAC Interventional Oncology Device Consumption Market Share by Application (2015-2020)
Table 46. Europe Interventional Oncology Device Consumption by Countries (2015-2020) (K Units)
Table 47. Europe Interventional Oncology Device Consumption Market Share by Countries (2015-2020)
Table 48. Europe Interventional Oncology Device Value by Countries (2015-2020) ($ Millions)
Table 49. Europe Interventional Oncology Device Value Market Share by Countries (2015-2020)
Table 50. Europe Interventional Oncology Device Consumption by Type (2015-2020) (K Units)
Table 51. Europe Interventional Oncology Device Consumption Market Share by Type (2015-2020)
Table 52. Europe Interventional Oncology Device Consumption by Application (2015-2020) (K Units)
Table 53. Europe Interventional Oncology Device Consumption Market Share by Application (2015-2020)
Table 54. Middle East & Africa Interventional Oncology Device Consumption by Countries (2015-2020) (K Units)
Table 55. Middle East & Africa Interventional Oncology Device Consumption Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Interventional Oncology Device Value by Countries (2015-2020) ($ Millions)
Table 57. Middle East & Africa Interventional Oncology Device Value Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Interventional Oncology Device Consumption by Type (2015-2020) (K Units)
Table 59. Middle East & Africa Interventional Oncology Device Consumption Market Share by Type (2015-2020)
Table 60. Middle East & Africa Interventional Oncology Device Consumption by Application (2015-2020) (K Units)
Table 61. Middle East & Africa Interventional Oncology Device Consumption Market Share by Application (2015-2020)
Table 62. Interventional Oncology Device Distributors List
Table 63. Interventional Oncology Device Customer List
Table 64. Global Interventional Oncology Device Consumption Forecast by Countries (2021-2025) (K Units)
Table 65. Global Interventional Oncology Device Consumption Market Forecast by Regions
Table 66. Global Interventional Oncology Device Value Forecast by Countries (2021-2025) ($ Millions)
Table 67. Global Interventional Oncology Device Value Market Share Forecast by Regions
Table 68. Global Interventional Oncology Device Consumption Forecast by Type (2021-2025) (K Units)
Table 69. Global Interventional Oncology Device Consumption Market Share Forecast by Type (2021-2025)
Table 70. Global Interventional Oncology Device Value Forecast by Type (2021-2025) ($ Millions)
Table 71. Global Interventional Oncology Device Value Market Share Forecast by Type (2021-2025)
Table 72. Global Interventional Oncology Device Consumption Forecast by Application (2021-2025) (K Units)
Table 73. Global Interventional Oncology Device Consumption Market Share Forecast by Application (2021-2025)
Table 74. Global Interventional Oncology Device Value Forecast by Application (2021-2025) ($ Millions)
Table 75. Global Interventional Oncology Device Value Market Share Forecast by Application (2021-2025)
Table 76. AngioDynamics, Inc. Product Offered
Table 77. AngioDynamics, Inc. Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 78. AngioDynamics, Inc. Main Business
Table 79. AngioDynamics, Inc. Latest Developments
Table 80. AngioDynamics, Inc. Basic Information, Company Total Revenue (in $ million), Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 81. Merit Medical Systems, Inc. Product Offered
Table 82. Merit Medical Systems, Inc. Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 83. Merit Medical Systems, Inc. Main Business
Table 84. Merit Medical Systems, Inc. Latest Developments
Table 85. Merit Medical Systems, Inc. Basic Information, Company Total Revenue (in $ million), Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 86. BD Product Offered
Table 87. BD Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 88. BD Main Business
Table 89. BD Latest Developments
Table 90. BD Basic Information, Company Total Revenue (in $ million), Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 91. BTG Plc Product Offered
Table 92. BTG Plc Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 93. BTG Plc Main Business
Table 94. BTG Plc Latest Developments
Table 95. BTG Plc Basic Information, Company Total Revenue (in $ million), Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 96. Eckert & Ziegler BEBIG Product Offered
Table 97. Eckert & Ziegler BEBIG Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 98. Eckert & Ziegler BEBIG Main Business
Table 99. Eckert & Ziegler BEBIG Latest Developments
Table 100. Eckert & Ziegler BEBIG Basic Information, Company Total Revenue (in $ million), Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 101. Boston Scientific Corporation Product Offered
Table 102. Boston Scientific Corporation Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 103. Boston Scientific Corporation Main Business
Table 104. Boston Scientific Corporation Latest Developments
Table 105. Boston Scientific Corporation Basic Information, Company Total Revenue (in $ million), Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 106. Medtronic PLC Product Offered
Table 107. Medtronic PLC Basic Information, Company Total Revenue (in $ million), Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 108. Medtronic PLC Main Business
Table 109. Medtronic PLC Latest Developments
Table 110. Medtronic PLC Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 111. HealthTronics, Inc. Product Offered
Table 112. HealthTronics, Inc. Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 113. HealthTronics, Inc. Main Business
Table 114. HealthTronics, Inc. Latest Developments
Table 115. HealthTronics, Inc. Basic Information, Company Total Revenue (in $ million), Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 116. Medwaves, Inc. Product Offered
Table 117. Medwaves, Inc. Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 118. Medwaves, Inc. Main Business
Table 119. Medwaves, Inc. Latest Developments
Table 120. Medwaves, Inc. Basic Information, Company Total Revenue (in $ million), Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 121. IceCure Medical Product Offered
Table 122. IceCure Medical Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 123. IceCure Medical Main Business
Table 124. IceCure Medical Latest Developments
Table 125. IceCure Medical Basic Information, Company Total Revenue (in $ million), Interventional Oncology Device Manufacturing Base, Sales Area and Its Competitors
Table 126. Cook Meidical LLC Product Offered
Table 127. Cook Meidical LLC Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 128. Cook Meidical LLC Main Business
Table 129. Cook Meidical LLC Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 130. Cook Meidical LLC Latest Developments
Table 131. Sanarus Technologies, Inc. Product Offered
Table 132. Sanarus Technologies, Inc. Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 133. Sanarus Technologies, Inc. Main Business
Table 134. Sanarus Technologies, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 135. Sanarus Technologies, Inc. Latest Developments
Table 136. Terumo Corporation Product Offered
Table 137. Terumo Corporation Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 138. Terumo Corporation Main Business
Table 139. Terumo Corporation Latest Developments
Table 140. Terumo Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 141. Sonacare Medical Product Offered
Table 142. Sonacare Medical Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 143. Sonacare Medical Main Business
Table 144. Sonacare Medical Latest Developments
Table 145. Sonacare Medical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 146. Trod Medical Product Offered
Table 147. Trod Medical Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 148. Trod Medical Main Business
Table 149. Trod Medical Latest Developments
Table 150. Trod Medical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 151. Sirtex Medical Ltd. Product Offered
Table 152. Sirtex Medical Ltd. Interventional Oncology Device Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 153. Sirtex Medical Ltd. Main Business
Table 154. Sirtex Medical Ltd. Latest Developments
Table 155. Sirtex Medical Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Interventional Oncology Device
Figure 2. Interventional Oncology Device Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Interventional Oncology Device Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Interventional Oncology Device Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Ablation Devices
Figure 7. Product Picture of Embolization Devices
Figure 8. Product Picture of Supporting Devices
Figure 9. Product Picture of Next Generation Devices
Figure 10. Global Interventional Oncology Device Consumption Market Share by Type (2015-2020)
Figure 11. Global Interventional Oncology Device Value Market Share by Type (2015-2020)
Figure 12. Interventional Oncology Device Consumed in Hospitals
Figure 13. Global Interventional Oncology Device Market: Hospitals (2015-2020) (K Units)
Figure 14. Global Interventional Oncology Device Market: Hospitals (2015-2020) ($ Millions)
Figure 15. Interventional Oncology Device Consumed in Specialty Clinics and Ambulatory Surgical Centers
Figure 16. Global Interventional Oncology Device Market: Specialty Clinics and Ambulatory Surgical Centers (2015-2020) (K Units)
Figure 17. Global Interventional Oncology Device Market: Specialty Clinics and Ambulatory Surgical Centers (2015-2020) ($ Millions)
Figure 18. Interventional Oncology Device Consumed in Others (Homecare and Research Institutes)
Figure 19. Global Interventional Oncology Device Market: Others (Homecare and Research Institutes) (2015-2020) (K Units)
Figure 20. Global Interventional Oncology Device Market: Others (Homecare and Research Institutes) (2015-2020) ($ Millions)
Figure 21. Global Interventional Oncology Device Consumption Market Share by Application (2015-2020)
Figure 22. Global Interventional Oncology Device Value Market Share by Application (2015-2020)
Figure 23. Global Interventional Oncology Device Sales Market Share by Company in 2017
Figure 24. Global Interventional Oncology Device Sales Market Share by Company in 2019
Figure 25. Global Interventional Oncology Device Revenue Market Share by Company in 2017
Figure 26. Global Interventional Oncology Device Revenue Market Share by Company in 2019
Figure 27. Global Interventional Oncology Device Sale Price by Company in 2019
Figure 28. Global Interventional Oncology Device Consumption Market Share by Regions 2015-2020
Figure 29. Global Interventional Oncology Device Value Market Share by Regions 2015-2020
Figure 30. Americas Interventional Oncology Device Consumption 2015-2020 (K Units)
Figure 31. Americas Interventional Oncology Device Value 2015-2020 ($ Millions)
Figure 32. APAC Interventional Oncology Device Consumption 2015-2020 (K Units)
Figure 33. APAC Interventional Oncology Device Value 2015-2020 ($ Millions)
Figure 34. Europe Interventional Oncology Device Consumption 2015-2020 (K Units)
Figure 35. Europe Interventional Oncology Device Value 2015-2020 ($ Millions)
Figure 36. Middle East & Africa Interventional Oncology Device Consumption 2015-2020 (K Units)
Figure 37. Middle East & Africa Interventional Oncology Device Value 2015-2020 ($ Millions)
Figure 38. Americas Interventional Oncology Device Consumption Market Share by Countries in 2019
Figure 39. Americas Interventional Oncology Device Value Market Share by Countries in 2019
Figure 40. Americas Interventional Oncology Device Consumption Market Share by Type in 2019
Figure 41. Americas Interventional Oncology Device Consumption Market Share by Application in 2019
Figure 42. United States Interventional Oncology Device Consumption Growth 2015-2020 (K Units)
Figure 43. United States Interventional Oncology Device Value Growth 2015-2020 ($ Millions)
Figure 44. Canada Interventional Oncology Device Consumption Growth 2015-2020 (K Units)
Figure 45. Canada Interventional Oncology Device Value Growth 2015-2020 ($ Millions)
Figure 46. Mexico Interventional Oncology Device Consumption Growth 2015-2020 (K Units)
Figure 47. Mexico Interventional Oncology Device Value Growth 2015-2020 ($ Millions)
Figure 48. APAC Interventional Oncology Device Consumption Market Share by Countries in 2019
Figure 49. APAC Interventional Oncology Device Value Market Share by Regions in 2019
Figure 50. APAC Interventional Oncology Device Consumption Market Share by Type in 2019
Figure 51. APAC Interventional Oncology Device Consumption Market Share by Application in 2019
Figure 52. China Interventional Oncology Device Consumption Growth 2015-2020 (K Units)
Figure 53. China Interventional Oncology Device Value Growth 2015-2020 ($ Millions)
Figure 54. Japan Interventional Oncology Device Consumption Growth 2015-2020 (K Units)
Figure 55. Japan Interventional Oncology Device Value Growth 2015-2020 ($ Millions)
Figure 56. Korea Interventional Oncology Device Consumption Growth 2015-2020 (K Units)
Figure 57. Korea Interventional Oncology Device Value Growth 2015-2020 ($ Millions)
Figure 58. Southeast Asia Interventional Oncology Device Consumption Growth 2015-2020 (K Units)
Figure 59. Southeast Asia Interventional Oncology Device Value Growth 2015-2020 ($ Millions)
Figure 60. India Interventional Oncology Device Consumption Growth 2015-2020 (K Units)
Figure 61. India Interventional Oncology Device Value Growth 2015-2020 ($ Millions)
Figure 62. Australia Interventional Oncology Device Consumption Growth 2015-2020 (K Units)
Figure 63. Australia Interventional Oncology Device Value Growth 2015-2020 ($ Millions)
Figure 64. Europe Interventional Oncology Device Consumption Market Share by Countries in 2019
Figure 65. Europe Interventional Oncology Device Value Market Share by Countries in 2019
Figure 66. Europe Interventional Oncology Device Consumption Market Share by Type in 2019
Figure 67. Europe Interventional Oncology Device Consumption Market Share by Application in 2019
Figure 68. Germany Interventional Oncology Device Consumption Growth 2015-2020 (K Units)
Figure 69. Germany Interventional Oncology Device Value Growth 2015-2020 ($ Millions)
Figure 70. France Interventional Oncology Device Consumption Growth 2015-2020 (K Units)
Figure 71. France Interventional Oncology Device Value Growth 2015-2020 ($ Millions)
Figure 72. UK Interventional Oncology Device Consumption Growth 2015-2020 (K Units)
Figure 73. UK Interventional Oncology Device Value Growth 2015-2020 ($ Millions)
Figure 74. Italy Interventional Oncology Device Consumption Growth 2015-2020 (K Units)
Figure 75. Italy Interventional Oncology Device Value Growth 2015-2020 ($ Millions)
Figure 76. Russia Interventional Oncology Device Consumption Growth 2015-2020 (K Units)
Figure 77. Russia Interventional Oncology Device Value Growth 2015-2020 ($ Millions)
Figure 78. Middle East & Africa Interventional Oncology Device Consumption Market Share by Countries in 2019
Figure 79. Middle East & Africa Interventional Oncology Device Value Market Share by Countries in 2019
Figure 80. Middle East & Africa Interventional Oncology Device Consumption Market Share by Type in 2019
Figure 81. Middle East & Africa Interventional Oncology Device Consumption Market Share by Application in 2019
Figure 82. Egypt Interventional Oncology Device Consumption Growth 2015-2020 (K Units)
Figure 83. Egypt Interventional Oncology Device Value Growth 2015-2020 ($ Millions)
Figure 84. South Africa Interventional Oncology Device Consumption Growth 2015-2020 (K Units)
Figure 85. South Africa Interventional Oncology Device Value Growth 2015-2020 ($ Millions)
Figure 86. Israel Interventional Oncology Device Consumption Growth 2015-2020 (K Units)
Figure 87. Israel Interventional Oncology Device Value Growth 2015-2020 ($ Millions)
Figure 88. Turkey Interventional Oncology Device Consumption Growth 2015-2020 (K Units)
Figure 89. Turkey Interventional Oncology Device Value Growth 2015-2020 ($ Millions)
Figure 90. GCC Countries Interventional Oncology Device Consumption Growth 2015-2020 (K Units)
Figure 91. GCC Countries Interventional Oncology Device Value Growth 2015-2020 ($ Millions)
Figure 92. Global Interventional Oncology Device Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 93. Global Interventional Oncology Device Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 94. Americas Interventional Oncology Device Consumption 2021-2025 (K Units)
Figure 95. Americas Interventional Oncology Device Value 2021-2025 ($ Millions)
Figure 96. APAC Interventional Oncology Device Consumption 2021-2025 (K Units)
Figure 97. APAC Interventional Oncology Device Value 2021-2025 ($ Millions)
Figure 98. Europe Interventional Oncology Device Consumption 2021-2025 (K Units)
Figure 99. Europe Interventional Oncology Device Value 2021-2025 ($ Millions)
Figure 100. Middle East & Africa Interventional Oncology Device Consumption 2021-2025 (K Units)
Figure 101. Middle East & Africa Interventional Oncology Device Value 2021-2025 ($ Millions)
Figure 102. United States Interventional Oncology Device Consumption 2021-2025 (K Units)
Figure 103. United States Interventional Oncology Device Value 2021-2025 ($ Millions)
Figure 104. Canada Interventional Oncology Device Consumption 2021-2025 (K Units)
Figure 105. Canada Interventional Oncology Device Value 2021-2025 ($ Millions)
Figure 106. Mexico Interventional Oncology Device Consumption 2021-2025 (K Units)
Figure 107. Mexico Interventional Oncology Device Value 2021-2025 ($ Millions)
Figure 108. Brazil Interventional Oncology Device Consumption 2021-2025 (K Units)
Figure 109. Brazil Interventional Oncology Device Value 2021-2025 ($ Millions)
Figure 110. China Interventional Oncology Device Consumption 2021-2025 (K Units)
Figure 111. China Interventional Oncology Device Value 2021-2025 ($ Millions)
Figure 112. Japan Interventional Oncology Device Consumption 2021-2025 (K Units)
Figure 113. Japan Interventional Oncology Device Value 2021-2025 ($ Millions)
Figure 114. Korea Interventional Oncology Device Consumption 2021-2025 (K Units)
Figure 115. Korea Interventional Oncology Device Value 2021-2025 ($ Millions)
Figure 116. Southeast Asia Interventional Oncology Device Consumption 2021-2025 (K Units)
Figure 117. Southeast Asia Interventional Oncology Device Value 2021-2025 ($ Millions)
Figure 118. India Interventional Oncology Device Consumption 2021-2025 (K Units)
Figure 119. India Interventional Oncology Device Value 2021-2025 ($ Millions)
Figure 120. Australia Interventional Oncology Device Consumption 2021-2025 (K Units)
Figure 121. Australia Interventional Oncology Device Value 2021-2025 ($ Millions)
Figure 122. Germany Interventional Oncology Device Consumption 2021-2025 (K Units)
Figure 123. Germany Interventional Oncology Device Value 2021-2025 ($ Millions)
Figure 124. France Interventional Oncology Device Consumption 2021-2025 (K Units)
Figure 125. France Interventional Oncology Device Value 2021-2025 ($ Millions)
Figure 126. UK Interventional Oncology Device Consumption 2021-2025 (K Units)
Figure 127. UK Interventional Oncology Device Value 2021-2025 ($ Millions)
Figure 128. Italy Interventional Oncology Device Consumption 2021-2025 (K Units)
Figure 129. Italy Interventional Oncology Device Value 2021-2025 ($ Millions)
Figure 130. Russia Interventional Oncology Device Consumption 2021-2025 (K Units)
Figure 131. Russia Interventional Oncology Device Value 2021-2025 ($ Millions)
Figure 132. Spain Interventional Oncology Device Consumption 2021-2025 (K Units)
Figure 133. Spain Interventional Oncology Device Value 2021-2025 ($ Millions)
Figure 134. Egypt Interventional Oncology Device Consumption 2021-2025 (K Units)
Figure 135. Egypt Interventional Oncology Device Value 2021-2025 ($ Millions)
Figure 136. South Africa Interventional Oncology Device Consumption 2021-2025 (K Units)
Figure 137. South Africa Interventional Oncology Device Value 2021-2025 ($ Millions)
Figure 138. Israel Interventional Oncology Device Consumption 2021-2025 (K Units)
Figure 139. Israel Interventional Oncology Device Value 2021-2025 ($ Millions)
Figure 140. Turkey Interventional Oncology Device Consumption 2021-2025 (K Units)
Figure 141. Turkey Interventional Oncology Device Value 2021-2025 ($ Millions)
Figure 142. GCC Countries Interventional Oncology Device Consumption 2021-2025 (K Units)
Figure 143. GCC Countries Interventional Oncology Device Value 2021-2025 ($ Millions)
Figure 144. AngioDynamics, Inc. Interventional Oncology Device Market Share (2018-2020)
Figure 145. Merit Medical Systems, Inc. Interventional Oncology Device Market Share (2018-2020)
Figure 146. BD Interventional Oncology Device Market Share (2018-2020)
Figure 147. BTG Plc Interventional Oncology Device Market Share (2018-2020)
Figure 148. Eckert & Ziegler BEBIG Interventional Oncology Device Market Share (2018-2020)
Figure 149. Boston Scientific Corporation Interventional Oncology Device Market Share (2018-2020)
Figure 150. Medtronic PLC Interventional Oncology Device Market Share (2018-2020)
Figure 151. HealthTronics, Inc. Interventional Oncology Device Market Share (2018-2020)
Figure 152. Medwaves, Inc. Interventional Oncology Device Market Share (2018-2020)
Figure 153. IceCure Medical Interventional Oncology Device Market Share (2018-2020)
Figure 154. Cook Meidical LLC Interventional Oncology Device Market Share (2018-2020)
Figure 155. Sanarus Technologies, Inc. Interventional Oncology Device Market Share (2018-2020)
Figure 156. Terumo Corporation Interventional Oncology Device Market Share (2018-2020)
Figure 157. Sonacare Medical Interventional Oncology Device Market Share (2018-2020)
Figure 158. Trod Medical Interventional Oncology Device Market Share (2018-2020)
Figure 159. Sirtex Medical Ltd. Interventional Oncology Device Market Share (2018-2020)
